“Although fasting diets have been criticised by nutritionists for being unhealthy, new research suggests starving the body kick-starts stem cells into producing new white blood cells, which fight off infection. Scientists at the University of Southern California say the discovery
The idea behind the company is to expel toxic, worn-out cells called “senescent cells.” Here’s the story in Fortune.
From STAT NEWS: The long-running Framingham Heart Study has found that “the rate of dementia was 3.6 percent in the late 1970s and early 1980s, falling to 2.8 percent a decade later, 2.2 percent a decade after that, and 2
Here’s the latest news piece to cite 100 Plus. The author interviewed some naysayers on the topic of healthspan, but ultimately I think it’s clear that if Silicon Valley can figure out how to increase human health, that is a
Here’s a well written article from Nature about how scientists should be focusing on aging in order to 1) treat a number of diseases and 2) extend healthspan for the many people who are in the ‘older’ demographic Go Nature!
I was honored to be on a panel tonight with tissue engineering pioneer Dr. Anthony Atala, Patient advocate Katie Jackson, and science artist Kelly Milukas. It was a fun panel and a great discussion about how to get more community
The Financial Times recently published a column arguing that “70 is the new 50.” That sounds about right to me at the moment, but it won’t stay that way for long. Longevity and — more importantly — health is about
The Financial Times posted an interesting article about Craig Venter and his new longevity company, Human Longevity Inc. When the journalist asks him if his company is in competition with Google’s Calico (also set up to extend human healthspan), Venter
Actress Blake Lively’s father was one of the first patients at the University of Utah in what looks like a groundbreaking procedure. Here’s a video as well. video platformvideo managementvideo solutionsvideo player
This Newsweek article contains an excellent conversation about longevity — how we might live longer and what that might mean. Here’s one of my favorite parts of the NW interview with Aubrey de Grey: NW: But would we really want
Cross-Posted from Singularityweblog.com: Just last month, regenerative medicine scored another solid victory by saving a toddler’s life. Yet, disappointingly, the news came and went without much follow-on thought. Hannah Warren, a Korean-Canadian girl who is now two years old, was
“A 2-year-old girl born without a windpipe now has a new one grown from her own stem cells, the youngest patient in the world to benefit from the experimental treatment.” Read more here from AP. And here’s a quote from
From Cnet: Backed by tech luminaries, the Breakthrough Prize in Life Sciences, a $3 million reward, is being presented to 11 different scientists for their efforts to cure diseases. Here’s a link to the actual prize site. Google’s Sergey Brin
Below is the video and here you will find the article that goes along with it. Jeff Glor, the correspondent who interviewed me, Peter Thiel, and Cynthia Kenyon, was super-smart and did a great job.
The NYT has a great article today about 61 year old Diana Nyad who is planning on swimming 60 hours straight with no sleep from Cuba to Key West. It’s a trek this record-holder attempted at age 28, but failed.
Here is an article from Reuters reporting on Aubrey de Grey’s lecture at Britain’s Royal Institution academy of science.
From Science Daily: A yet unidentified component of coffee interacts with the beverage’s caffeine, which could be a surprising reason why daily coffee intake protects against Alzheimer’s disease. A new Alzheimer’s mouse study by researchers at the University of South
This is a fantastic article. At a time when Congress is debating a bloated $850 billion health care bill, doctors in India have come up with ways to make heart surgery cheaper, with potentially better recovery rates. According to the
“I could make a mouse that has your liver. That’s incredibly valuable,” said stem cell researcher Stephen A. Duncan (at the Medical College of Wisconsin). That’s an impressive claim, and it’s based on newly released data from his lab that
From the NYT: “A team at the Broad Institute, a Harvard-M.I.T. collaborative for genomics research, has devised a way of screening for drugs that attack cancer stem cells but leave ordinary cells unharmed. The Broad team, lead by Piyush B.